Neonatal Hyperbilirubinemia (Pathologic) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Neonatal Hyperbilirubinemia (Pathologic)
Neonatal hyperbilirubinemia pathologic refers to jaundice in newborns that is more severe or appears earlier than typical physiological jaundice, indicating an underlying medical issue. It's caused by an excessive buildup of bilirubin, a yellow pigment, in the baby's blood. While mild jaundice is common, pathologic jaundice can lead to serious complications like kernicterus, a type of brain damage, if left untreated. Causes can include blood group incompatibilities (like Rh or ABO), G6PD deficiency, infections, or liver conditions, requiring careful diagnosis and intervention.
The primary treatment for pathologic jaundice is phototherapy, where special lights help break down bilirubin in the skin, allowing the baby's body to excrete it more easily. In severe cases that don't respond to phototherapy, an exchange transfusion may be necessary to rapidly lower bilirubin levels. For specific underlying causes, such as isoimmune hemolytic disease, intravenous immunoglobulin (IVIG) may be administered to reduce antibody destruction of red blood cells. Medications like phenobarbital might be used in rare instances to help the liver process bilirubin, though less common for acute management
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.